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In this study, the glutathione (GSH) and lipid peroxidation profiles of normal, G6PD-deficient and sickle 
erythrocytes were assessed before (pre-APHZ) and after (Post-APHZ) induction of oxidative stress with 
acetyphenylhydraizine (APHZ). Lipid peroxidation was measured as the amount of malondialdehyde (MDA) 
produced per unit time (nmol hr1). Before treating the erythrocytes with APHZ, the mean GSH levels were 
39.82 ± 1.48, 36.00 ± 2.44 and 26.00 ± 2.32 mg /10 ml in normal subjects, G6PD-deficient subjects and sickle 
cell patients respectively. The post-APHZ treatment levels of GSH for the same categories of erythrocytes 
were 37.0 ± 3.25, 17.10 ± 0.011 and 13.00 ± 1.98 mg/ 100 ml respectively. This study revealed that in the 
absence of an oxidant stressor, normal red cells, and those of G6PD-deficient subjects maintain high levels 
of GSH and low levels of lipid peroxidation products (measured as malondialdehyde, MDA) and that the 
initial effects of exposure to oxidative stress are lower GSH and elevated MDA contents of the cells. This 
study further established that the erythrocytes of sickle cells patients, even without any exogenous oxidative 
challenge, have subsisting low levels of GSH and high levels of MDA, most probably because sickle cell 
complications give rise to high levels of redox species that constitute molecular threats to the integrity of red 
blood cells. It was also a finding in this study that the red cells of normal subjects respond less significantly 
to such oxidative stress-induced parameters of assessing red blood cell integrity-GSH content and lipid 
perodixation.  
 




Oxidative stress on cells or tissues is frequently 
caused by free radicals (FRs) - species that contain 
an unpaired or odd number of electrons and may 
posses a positive, a negative, or no charge (Snyder et 
al., 1982). FRs-mainly reactive oxygen species 
(ROS), reactive nitrogen species (RNs), and lipid 
peroxyl radicals (LPR)-are derived either from normal 
essential metabolic processes in the body (internal 
sources) or from external /environment sources (Ho et 
al., 2007). These FRs may be of organic or inorganic 
origin (Mason and Chignell, 1982) and are formed 
continuously in cells as a consequence of both 
enzymatic and non-enzymatic reactions (Bagchi and 
Puri, 1998). The enzymatic reactions which serve as 
sources of FRs include those involved in the 
respiratory chain, in phagocytosis, in prostaglandin 
synthesis and cytochrome P450 system (Langseth, 
1996). Accordingly, the internal sites/sources of FR 
generation are mitochondria, phagocytes, xanthine 
oxidase, reactions involving iron and other transition 
metal, arachidonate pathways (Ho et al., 2006). Free 
radicals also arise from non-enzymatic reactions of O2 
with organic compounds, including those initiated by 
ionizing radiation (UV), certain drugs, pesticides, 
anesthetics industrial solvents and ozone (Baumber 
et al., 2000). The human body employs two main lines 
of defence to counteract radical damages: a system 
of enzymes, and antioxidants (Uday et al., 1999). The 
primary line of defence, the enzymes, are glutathione 
peroxidase (GPx) superoxide dismutase (SOD), and 
catalase while the secondary line of defence is 
provided by the antioxidants and/or free radical 
scavengers such as α-tocopherol, ascorbic acid, 
retinol, β-carotene and glutathione (GSH). Oxidative 
stress engendered by an imbalance between the rate 
of FR production and enzymic and antioxidant 
defences in the body has been implicated in the 
pathogenesis and progression of many diseases (Ho 
et al., 2007; Ho et al., 2006; because the FRs mediate 
lipid peroxidation and destroy cellular proteins, lipids, 
carbohydrates and DNA (Eze, 1991). This study was 
therefore aimed at investigating drug-induced 
glutathione and lipid peroxidation profiles of normal, 
G6PF-deficient and sickle erythrocytes.  
 
Materials and Methods 
 
Subject: Glucose-6-phosphate dehydrogenase 
(G6PD) screening test procedures was used  to 
analyze the 90 blood samples collected from 30 each 
of G6PD-deficient sickle cell patients (SCPs), G6PD-
deficient but non-sickle cell subjects (NSCs) and 
normal subjects (NSs). The SCPs were selected from 
those attending routine checkups at the Federal 
Medical Center, Abakaliki, Nigeria, while the NSCs 
and NSCs were selected from the staff and students 
of the College of Health Sciences, Ebonyi State 
University, Abakaliki. They (NSCs and NSs) were not 
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taking any drug and the SCPs were not having any 
crisis at the times the blood samples were collected.  
 
Chemicals:  All the chemicals used in this study were 
of analytical grade (Anal. AR).  
 
Glutathione assay: Oxidative stress was induced in 
the erythrocytes by adding 5 mg of 
acetylphenylhydrazine (APHZ) per ml of whole blood. 
Glutathione concentrations were determined 
according to the acid-citrate-D-glucose (ACD) method 
of Beutler (1966). These measurements were done 
pre-and post-APHZ treatments.  
 
Lipid Peroxidation Assay: MDA levels of whole 
blood samples were determined per-and post-APHZ 
treatment at 5 mg APHZ/ ml by the method described 
by Siroev and Makarova (1989).  
 
Data analysis: The difference in treatment mean 




Glutathione levels: Before APHZ treatment, the 
mean GSH level in normal subjects (Fig. 1) was 
greater than that the mean level in G6PD-deficient 
subjects (39.82 vs 26.00 mg /100 ml) (Fig. 2), and the 
level in G6PD-deficient subjects was greater than that 
of sickle cell patients (36.00 vs 26.00 mg/ml). 
Incubating the red cells with APHZ caused an 
insignificant (p > 0.05) in reduction in the mean GSH 
level of normal subjects (39.82 vs 37.00 mg/100 ml) 
when compared with the significant drop (p < 0.05) in 
G6PD-deficient red cells (36.00 vs 17.10 mg/100 ml), 
and sickle red cells (from 26.00 to 13.00 mg/100 ml).  
 
Lipid peroxidation (MDA): In the absence of APHZ, 
minimal lipid peroxidation occurred in normal (Fig. 3) 
and G6PD-deficient subjects (3.01 and 4.00 nmol/hr 
respectively) (Fig. 4). The lipid peroxidation level in 
sickle cell patients was high (210.91 nmol/hr) under 
the same condition. Upon incubation with APHZ, 
mean MDA level still remained low in normal subjects 
(5.90 nmol/hr) when compared with G6PD-deficient 
subjects (260.10 nmol/hr) and sickle cell patients 




Prior to inducing oxidative stress in the three 
categories  of erythrocytes-those of normal, G6PD-
deficient and sickle cell patients (Fig. 1) normal and 
G6PD-deficient red cells both had high mean 
glutathione contents of 9.82 and 36 mg/100ml 
respectively. This was suggestive of a functional 
pentose phosphate pathway (PPP), the main source 
of NADPH that maintains glutathione in the reduced 
form-GSH. This was also indicative of the existence of 
low levels of oxidant stressors, particularly free 
radicals which are usually kept in check or impaired.  
 
 
Fig. 2: Glutathione levels in
normal subjects, G6PD-deficient
























Fig. 1: Glutathione levels in
normal subjects, G6PD-deficient




























































At this baseline (pre-APHZ) however, the mean GSH 
level of sickle erythrocytes was much lower (26 
mg/100ml) than those of the other two categories. It is 
reasonable to infer that even in the absence of 
oxidative challenge; there is a subsisting high level of 
endogenously derived reactive species which 
continually deplete the GSH levels of these cells. 
Although normal red cells should have optimal G6PD 
activity, which generates NADPH to promptly reduce 
the GSSG that is continually generated, fig 2 indicates 
that APHZ caused an initial fall, though insignificantly 
(p > 0.05), in the mean GSH level of those cells, but 
insignificantly (p < 0.05) in G6PD-deficient and sickle 
red cells. From the APHZ-induced drops in the GSH 
levels of these cells, it can be inferred that at least 
one of the initial effects of an oxidant drug on red cells 
is to lower their GSH levels. Since red cell glutathione 
is maintained in the reduced state (GSH) by the 
NADPH generated by G6PD, it is also reasonable to 
infer that the initial effect of an oxidant drug is to lower 
the activity of the enzyme, so that less NADPH is 
available to reduce GSSG to GSH. This accounts, at 
least in part, for the reduced levels of this intracellular 
thiol when the cells were exposed to APHZ.  
 
 








































Alternatively, this effect (lowering of GSH level) could 
be due to the activation of γ-glutamyltranspeptidase, 
an enzyme located on the external surfaces of red 
cells and which initiated with degradation of GSH in 
vivo (Voet and Voet, 1994). The significant (p < 0.05) 
fall in the mean GSH level of G6PD-deficient 
erythrocytes was expected in view of the documented 
low activity of G6PD in these cells upon exposure to 
oxidative stress and, by extension, low level of 
NADPH needed to keep GSH in its reduced form. 
Much as low G6PD activity and subsequent low 
NADPH level could also account for the lowering of 
the mean level of GSH in sickle erythrocytes, the very 
low level of GSH in these cells pre-APHZ treatment 
demands other explanations. This finding was 
agreement with the studies of Ho et al., (2007) in 
which they concluded that sickle cell complications 
cause the red cells to produce very high levels of 
reactive oxygen and nitrogen species which 
overwhelm the enzymic and antioxidant defences 
against those redox species. 
The lipid peroxidation profiles of the three 
categories of red cells used in this study mirrored 
those of GSH. Before the red cells were treated with 
APHZ, the lipid peroxidation products (MDA) in 
normal and G6PD-deficient subjects were low. This 
was a converse reflection of the high level of GSH 
(and possibly other defense against free radical 
damages) in these cells. On the other hand, a high 
pre-APHZ level of MDA (210.90 vs 3. 01 and 4.00 
nmol/hr) (fig 3) existed in sickle erythrocytes, and this 
was very much in agreement with the much lower 
mean level of GSH (26 vs 39 and 36 mls) in these 
cells. In the same way that mean GSH levels of 
normal and G6PD-deficient cells dropped upon 
exposure to APHZ, there were respectively 
insignificant (p> 0.05) upregulation of mean MDA 
level in normal subjects, but significant (p < 0.05) 
rises in the mean MDA levels of G6PD-deficient and 
sickle red cells.  
Fig. 3: Lipid peroxidation levels 
in normal subjects, G6PD-
deficient subjects, and sickle

























Fig. 4: Lipid peroxidation levels in 
normal subjects, G6PD-deficient



























 This study has shown that in the absence of 
an oxidative challenge, the red cells of normal and 
G6DP-deficient subjects maintain high levels of GSH 
and low levels of lipid peroxidation products (MDA) 
respectively. It has also shown that sickle 
erythrocytes, even in the absence of oxidant 
stressors, have a subsisting high level of MDA and a 
low level of GSH. It was also a finding in this study, 
that the initial effect of an oxidant substance (drug) on 
red cells is to lower their GSH levels and elevate their 
MDA levels, and that normal red cells, with efficient 
pentose phosphate pathways, counteract these 
effects while those of G6PD-deficient subjects and 
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